Dr. Sheela Godbole          Publications 

Designation:  Scientist D

Department:  Epidemiology

E-mail address: sgodbole@nariindia.org

Educational Qualification:

Degree	Year	Institution
M.D.	1992	B. J. Medical College, University of Pune
M.B.B.S.	1988	B. J. Medical College, University of Pune
Awards and Honours: 1. A.C.Parikh award for Best Case Paper presentation (on Porokeratosis), presented by Indian Association of Dermatologists and Venereologists Maharashtra Branch 1992. 2. Best Participant award: WHO Disease Burden Workshop 2001. 3. Young Achievers Award for Women: for contributions in the field of Health and Medicine in Pune City 2003.The award was given by the All India Women’s Conference: Platinum Jubilee Year Organizing Committee in Pune, for contributions to the field of Health and Medicine in Pune over the last decade. 4. Traineeship Award: University of California Los Angles, Advanced AIDS Research and Training Program (AITRP) 2008
Research Experience: CRS Site Leader and Co-investigator: NARI-NIV Clinical Research Site at the NARI Pune Clinical Trials Unit (CTU) funded by Division of AIDS. 5U01AI69417-02 (Mehendale) Principal Investigator/ Co-PI: 1. Estimation of HIV Disease burden in Pune and Maharashtra. ( A NARI intra mural project) Completed. 2. Prevalence of HIV in Cutaneous adverse drug reactions presenting to a tertiary care centre in Pune India. (Completed) 3. Evaluation of provider, patient and pharmacy knowledge, attitudes and practices regarding HIV care and use of antiretroviral therapy in Pune, India (A NARI -JHU collaborative study) Investigator of Record: 1. HPTN 052 study: A Randomized Trial to Evaluate the Effectiveness of Antiretroviral Therapy plus HIV Primary Care versus HIV Primary Care Alone to Prevent the Sexual Transmission of HIV-1in Serodiscordant Couples. A multi-centric, randomized open label clinical trial using antiretroviral drugs (IND). Protocol version 3.0 March 2007 onwards Co-investigator: 1. HPTN 034 study: Incidence and retention protocol of HIV Discordant couples and High risk sero-negative women in Pune. Involved in implementation, training, raising serodiscordant cohort, follow up and clinical care of participants. (Completed) 2. HPTN 052 study: A Randomized Trial to Evaluate the Effectiveness of Antiretroviral Therapy plus HIV Primary Care versus HIV Primary Care Alone to Prevent the Sexual Transmission of HIV-1in Serodiscordant Couples. A multi-centric, randomized open label clinical trial using antiretroviral drugs (IND). Protocol version 2.0 Involved as Study Coordinator until March 2007 3. HPTN 047 study (Phase I study of PRO 2000 gel a vaginal microbicide) (Completed) 4. A5175 study and other NARI-ACTU studies (A5190, 5199) Multicentric Antiretroviral Clinical Trials under the aegis of AIDS Clinical Trials Group (ACTG): A5175: A phase III, randomized, open-label evaluation of the efficacy of once-daily protease inhibitor and once-daily non-nucleoside reverse transcriptase inhibitor-containing combinations for initial treatment of hiv-1 infected subjects in Resource-limited countries. Ongoing 5. Phase I and II Safety and toxicity assessment of ‘Praneem’ polyherbal preparation as a vaginal microbicide. 6. NeuroAIDs and Dementia Study Member Ethics Committee- Maharashtra University of Health Sciences, UDIRT Nasik. Member Steering Committee: ‘Prenahtest’ an ANRS funded study on counseling interventions to promote prenatal couples HIV testing implemented by Prayas. HIV Sentinel Surveillance: 2006, 2007 She is involved as an epidemiologist and field coordinator in HIV Sentinel Surveillance 2006, 2007 as Regional Institute team member for western states of India for National AIDS Control Organization (NACO), Government of India. Faculty: ART Access Training programs for Medical Officers and laboratory technologists
<< Back   Next >>